# Treatment of Parkinson Disease and Multiple System Atrophy Using Intranasal Insulin.

> **NCT02064166** · PHASE2 · COMPLETED · sponsor: **Peter Novak** · enrollment: 15 (actual)

## Conditions studied

- Parkinson Disease
- Multiple System Atrophy

## Interventions

- **DRUG:** Intranasal Insulin

## Key facts

- **NCT ID:** NCT02064166
- **Lead sponsor:** Peter Novak
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2014-02
- **Primary completion:** 2015-09
- **Final completion:** 2015-09
- **Target enrollment:** 15 (ACTUAL)
- **Last updated:** 2018-11-23


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02064166

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02064166, "Treatment of Parkinson Disease and Multiple System Atrophy Using Intranasal Insulin.". Retrieved via AI Analytics 2026-05-24 from https://api.ai-analytics.org/clinical/NCT02064166. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*